Page
Menu
  Sitemap

Welcome To Sweet Coconut Lime

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group..
. Scand J Gastroenterol Suppl. 1988;155:23-8. doi: 10.3109/00365528809096277. Scand J Gastroenterol Suppl. 1988. PMID: 3072665 Review..

top
Home
Page
Menu